 Shares of Cassava Sciences NASDAQ: SAVA stock are in the spotlight following the companys third-quarter earnings and a stark warning to short sellers. During Q3, the company reported a net loss of 20.3 million, equivalent to an EPS loss of 51 cents per share. 